Cervical cancer is a form of cancer that affects the cervix. It is one of the most preventable forms of cancer. Early detection is crucial, as this type of cancer can spread to other areas of the body. Although it can be deadly, it can also be controlled and even eradicated within a generation.
Cervical cancer is currently the leading cause of cancer mortality among women worldwide. According to World Health Organization 2018, around 90% of deaths from cervical cancer occurred in low- and middle-income countries. Human papillomavirus (HPV) vaccination has the potential to substantially decrease this burden. The U.S. Food and Drug Administration has approved three vaccines including Cervarix, Gardasil, and Gardasil 9 that aid in preventing HPV infections, which are leading causes of cervical cancer.
The cervical cancer vaccines market size was valued at US$ 2,595.4 million in 2021, and is expected to witness a CAGR of 12.1% over the forecast period (2022 – 2028).
Get Free Sample PDF Copy (Including Full TOC, List of Tables & Figures, Chart) @
Government are focusing on increasing awareness among the populace regarding cervical cancer and its treatments such as free vaccination. This is expected to drive growth of the global cervical cancer vaccines market. For instance, according to American Society of Clinical Oncology (ASCO) 2018, the government of Rwanda aims to eradicate cervical cancer by 2020 by immunizing all adolescent girls between 11 and 15 years of age.
High cost associated with the treatment of cervical cancer is projected to hinder growth of the global cervical cancer vaccines market over the forecast period. For instance, according to National Center for Biotechnology Information (NCBI) 2017, the cost of cervical cancer treatment ranged from US$ 368 – US$ 11,400 depending on the type of hospital and treatment involved. HPV vaccination is likely to be very cost-effective with an incremental cost per disability-adjusted life year (DALY) averted in the range US$ 780 – US$ 1,120. However, under list prices for Cervarix and Gardasil in Vietnam, the incremental cost per DALY averted for HPV vaccination can exceed US$ 8000.
On the basis of region, the global cervical cancer vaccines market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is projected to hold leading position in the global cervical cancer vaccines market over the forecast period, due to growing prevalence of cervical cancer in the U.S. For instance according to National Cancer Institute, 2016, around 289,696 women were suffering from cervical cancer in the U.S. in 2016. Moreover, according to the American Cancer Society’s estimates, around 13,170 new cases of invasive cervical cancer will be diagnosed and 4,250 death of women will be registered from cervical cancer in the U.S. in 2019.
Request PDF Brochure with Latest Insights @
Asia Pacific is projected to foresee a rapid growth in the cervical cancer vaccines market over the forecast period owing to increasing approval of cervical cancer vaccines by the regulatory bodies. For instance, in 2016, China Food and Drug Administration (CFDA) approved Cervarix as the first HPV vaccine licensed for use in China against cervical cancer to meet the unmet needs of prevention of cervical cancers among Chinese population. According to National Center for Biotechnology Information 2018, China being the world’s largest developing country, exhibits a high incidence of cervical cancer with approximately 130,000 new cases each year.
Key players operating in the cervical cancer vaccines market include, GlaxoSmithKline PLC and Merck & Co. Inc.
Reasons to buy this Cervical Cancer Vaccines Market Report
◘ Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging Cervical Cancer Vaccines Market
◘ Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging Cervical Cancer Vaccines Market
◘ Leading company profiles reveal details of key Cervical Cancer Vaccines Market players emerging five operations and financial performance
◘ Add weight to presentations and pitches by understanding the future growth prospects of the emerging Cervical Cancer Vaccines Market with five year historical forecasts
◘ Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region
𝐁𝐮𝐲 𝐓𝐡𝐢𝐬 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐟𝐟 @
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Cervical Cancer Vaccines Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Cervical Cancer Vaccines Industry Impact
Chapter 2 Global Cervical Cancer Vaccines Competition by Types, Applications, and Top Regions and Countries
2.1 Global Cervical Cancer Vaccines (Volume and Value) by Type
2.3 Global Cervical Cancer Vaccines (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Cervical Cancer Vaccines Sales, Consumption, Export, Import by Regions
Chapter 5 North America Cervical Cancer Vaccines Market Analysis
Chapter 6 East Asia Cervical Cancer Vaccines Market Analysis
Chapter 7 Europe Cervical Cancer Vaccines Market Analysis
Chapter 8 South Asia Cervical Cancer Vaccines Market Analysis
Chapter 9 Southeast Asia Cervical Cancer Vaccines Market Analysis
Chapter 10 Middle East Cervical Cancer Vaccines Market Analysis
Chapter 11 Africa Cervical Cancer Vaccines Market Analysis
Chapter 12 Oceania Cervical Cancer Vaccines Market Analysis
Chapter 13 South America Cervical Cancer Vaccines Market Analysis
Chapter 14 Company Profiles and Key Figures in Cervical Cancer Vaccines Business
Chapter 15 Global Cervical Cancer Vaccines Market Forecast (2022-2028)
Chapter 16 Conclusions
About Coherent Market Insights
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027